Microfluidic synthesis of phosphatidylcholine liposomes for verbascoside delivery into C2C12 cells
Source abstract
Abstract
The interest of lipid vesicles for applications in the pharmaceutical field is increasing, especially for preparing drug and gene delivery vectors. There are different methods for the preparation of these vesicles, however, microfluidic-based methods provide significant advantages over other synthetic protocols like extrusion and sonication. In this study, monodisperse liposomes based on L-α-phosphatidylcholine were synthesized using a versatile capillary hydrodynamic flow-focusing device to deliver verbascoside into murine C2C12 muscle cells. The size and surface charge of the obtained liposomes were studied using Dynamic Light Scattering (DLS) and zeta-potential measurements. TEM and SAXS analyses were used to investigate the shape and lamellarity of the structures. By introducing a suitable dye into the phospholipid membrane of the liposomes and using confocal fluorescence microscopic analysis, liposomes internalization in C2C12 cells was confirmed in vitro. In addition, verbascoside encapsulation in the vesicles protected it efficiently, increasing its antioxidant activity against ROS production in C2C12 cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lipid Membrane Structure and Behavior · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Binaymotlagh R, HajarehHaghighi F, Chronopoulou L, Palocci C (2024) Liposome-Hydrogel composites for controlled drug delivery applications Gels 10:284
2. Tang J et al (2021) Liposome interaction with macrophages and foam cells for atherosclerosis treatment: effects of size, surface charge and lipid composition. Nanotechnology 32:50510.1088/1361-6528/ac2810 ↗
3. Atre P, Rizvi SAA (2024) A brief overview of quality by design approach for developing pharmaceutical liposomes as nano-sized parenteral drug delivery systems. RSC Pharm 1:675–68810.1039/D4PM00201F ↗
4. Van Der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL (2017) The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease Biochim. Biophys Acta 1859:155810.1016/j.bbamem.2017.04.006 ↗
5. Marrapu B, Mallampalli LK, Kaki SS, Rachapudi BNP (2015) A novel method to synthesize 1-acyl-sn-glycero-3-phosphocholine and 1,2-diacyl- sn -glycero-3-phosphocholine. Eur J Lipid Sci Technol 117:104910.1002/ejlt.201400615 ↗
6. Nsairat H, Khater D, Sayed U, Odeh F, Bawab AA, Alshaer W (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 8:e0939410.1016/j.heliyon.2022.e09394 ↗
7. Yamada M, Takizawa T, Kikuchi H (2008) Development of MITO-Porter: A liposome-based carrier system for delivering macromolecules into mitochondria via membrane fusion. J Nanopart Res 10:741
8. Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L (2000) Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 3:19–3010.1016/S0168-3659(99)00166-2 ↗
9. Mayer LD, Krishna R, Webb M, Bally M (2000) Designing liposomal anticancer drug formulations for specific therapeutic applications. J Liposome Res 10:99–11510.3109/08982100009029381 ↗
10. Ramachandran S, Quist AP, Kumar S, Lal R (2006) Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity. Langmuir 22:8156–6210.1021/la0607499 ↗
11. Musielak M, Potoczny J, Boś-Liedke A, Kozak M (2021) The combination of liposomes and metallic nanoparticles as multifunctional nanostructures in the therapy and Medical Imaging-A review. Int J Mol Sci 22:622910.3390/ijms22126229 ↗
12. Pilkington CP, Gispert I, Chui SY, JohnM S, Elani Y (2024) Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release. Nat Chem 16:161210.1038/s41557-024-01584-z ↗
13. Korgel BA, Monbouquette HG (1999) Controlled synthesis of mixed core and layered (Zn, Cd)S and (Hg, Cd)S nanocrystals within phosphatidylcholine vesicles. Langmuir 15:1611
14. Tamura T et al (2020) Organelle membrane-specific chemical labeling and dynamic imaging in living cells. Nat Chem Biol 16:136110.1038/s41589-020-00651-z ↗
15. Stano P, Kuruma Y, Souza TP, Luisi PL (2010) Biosynthesis of proteins inside liposomes. Methods Mol Biol 606:127–4510.1007/978-1-60761-447-0_11 ↗
16. Görlich D, Rapoport TA (1993) Protein translocation into proteoliposomes reconstituted from purified components of the endoplasmic reticulum membrane. Cell 75:615–63010.1016/0092-8674(93)90483-7 ↗
17. Pécheur EI, Martin I, Maier O, Bakowsky U, Ruysschaert JM, Hoekstra D (2002) Phospholipid species act as modulators in p97/p47-mediated fusion of Golgi membranes. Biochemistry 41:9813–2310.1021/bi0259195 ↗
18. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 13:e0939410.1016/j.heliyon.2022.e09394 ↗
19. Gregoriadis G (2021) Liposomes and mRNA: Two technologies together create a COVID-19 vaccine. Med Drug Discov 12:10010410.1016/j.medidd.2021.100104 ↗
20. Aranguren A, Torres CE, Muñoz-Camargo C, Osma JF, Cruz JC (2020) Synthesis of nanoscale liposomes via low-cost microfluidic systems. Micromachines 11:105010.3390/mi11121050 ↗
21. Jahn A, Reiner JE, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M (2008) Preparation of nanoparticles by continuous-flow microfluidics. J Nanopart Res 10:92510.1007/s11051-007-9340-5 ↗
22. Orekhova A, Palocci C, Chronopoulou C, De Angelis G, Badiali C, Petruccelli V, D’Angeli S, Pasqua G, Simonetti G (2022) Poly-(lactic-co-glycolic) acid nanoparticles entrapping pterostilbene for targeting aspergillus section nigri. Molecules 27:542410.3390/molecules27175424 ↗
23. Van Swaay D, deMello A (2013) Microfluidic methods for forming liposomes. Lab Chip 13:5210.1039/c2lc41121k ↗
24. Yu B, Lee RJ, Lee LJ (2009) Microfluidic methods for production of liposomes. Methods Enzymol 465:129–14110.1016/S0076-6879(09)65007-2 ↗
25. Alipieva K, Korkina L, Orhan IE, Georgiev MI (2014) Verbascoside-A review of its occurrence, (Bio)synthesis and pharmacological significance Biotechnol. Adv 32:1065
26. Funes L, Laporta O, Cerdán-Calero M, Micol V (2010) Effects of verbascoside, a phenylpropanoid glycoside from lemon verbena, on phospholipid model membranes. Chem Phys Lipids 163:190–910.1016/j.chemphyslip.2009.11.004 ↗
27. Sciandra F, Bozzi M, Bigotti MG (2023) From adhesion complex to signaling hub: the dual role of dystroglycan. Front Mol Biosci 10:132528410.3389/fmolb.2023.1325284 ↗
28. Round A et al (2015) BioSAXS Sample Changer: a robotic sample changer for rapid and reliable high-throughput X-ray solution scattering experiments. Acta Crystallogr D Biol Crystallogr 71:6710.1107/S1399004714026959 ↗
29. Burlew M (2005) SAS Guide to Report Writing Examples, 2nd edn. SAS Institute
30. Breßler I, Kohlbrecher J, Thünemann AF (2015) sasfit : a tool for small-angle scattering data analysis using a library of analytical expressions. J Appl Crystallogr 48:158710.1107/S1600576715016544 ↗
31. Briuglia ML, Rotella C, McFarlane A, Lamprou DA (2015) Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res 5:23110.1007/s13346-015-0220-8 ↗
32. Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige-Gerges H (2018) Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol 113:4010.1016/j.fct.2018.01.017 ↗
33. Chen W, Zou M, Ma X, Lv R, Ding T, Liu D (2019) Co-encapsulation of egcg and quercetin in liposomes for optimum antioxidant activity. J Food Sci 84:11110.1111/1750-3841.14405 ↗
34. Bhattacharjee S (2024) DLS and zeta potential-What they are and what they are not? J of Cont Release 235:33710.1016/j.jconrel.2016.06.017 ↗
35. Zhou F et al (2018) Chitosan-coated liposomes as delivery systems for improving the stability and oral bioavailability of acteoside. Food Hydrocoll 83:1710.1016/j.foodhyd.2018.04.040 ↗
36. Pabst G et al (2006) Small-angle X-ray scattering from model membranes. Biochim Biophys Acta - Biomembr 1758:1443
37. Israelachvili JN (2011) Intermolecular and surface forces. Academic Press
38. Marsh D (2008) Physical chemistry of lipids: From fatty acids to phospholipids. Springer SBM
39. Chabre Y et al (1994) Scattering from multilamellar and unilamellar vesicles. Biochim Biophys Acta - Biomembr 1222:193
40. Kato M et al (1995) Stability of unilamellar vesicles prepared by extrusion and sonication. Biophys J 69:1856
41. Salditt T et al (2009) SASFit: A software for the analysis of small-angle scattering data from liposomal and other complex systems. J Appl Crystallogr 42:1082
42. Hwang S et al (2005) Characterization of liposomal formulations: size, polydispersity, and stability. Langmuir 21:5167
43. Sessa G et al (1974) Multilamellar vesicles in liposome preparations: formation, properties, and behavior. Biochem Biophys Res Commun 58:1194
44. Barenholz Y (2015) Liposome applications: Review of current medical research. Nanomed Nanotechnol Biol Med 11:110.1016/j.nano.2014.05.009 ↗
45. Popova NL et al (2000) Application of transmission electron microscopy to study liposome-based drug delivery systems. Micron 31:385
46. Waring AJ et al (1993) The role of cholesterol in lipid membranes and liposomal formulations. Biophys J 65:57
47. Ipsen JH et al (1987) Phase equilibria of phospholipid bilayers: theory and experiments. Biochimica et Biophysica Acta - Biomembranes 905:16210.1016/0005-2736(87)90020-4 ↗
48. Almeida PF et al (1995) Modulation of lipid bilayer properties by cholesterol: Effects on the bilayer’s mechanical and structural properties. Biochim Biophys Acta (BBA) Biomembranes 1241:313
49. Brown WK et al (2006) Electron microscopy techniques for liposomal formulations. Colloids Surf B Biointerfaces 50:6